Literature DB >> 10555916

Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma.

T G Phan1, A Cass, A Gillin, P Trew, N Fertig, A Sturgess.   

Abstract

We describe the use of antibodies to RNA polymerase III in the diagnosis of scleroderma in 2 patients who presented with renal crisis without other clinical features of the condition. Both presented with accelerated hypertension, rapidly progressive acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. One patient developed digital infarcts in the course of his initial illness. Neither showed evidence of skin thickening at presentation. Nailfold capillaroscopy was normal in one patient and showed capillary dropout in the other. Renal biopsy showed findings consistent with thrombotic microangiopathy and both had anti-RNA polymerase III antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555916

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  IMPACT OF AGE AND AUTOANTIBODY STATUS ON THE GENE EXPRESSION OF SCLERODERMA FIBROBLASTS IN RESPONSE TO SILICA STIMULATION.

Authors:  Y Yang; P Wei; X J Guo; D Zhou; W Z Zhang; S Assassi; X D Zhou
Journal:  Eur J Inflamm       Date:  2013-09       Impact factor: 0.466

2.  Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.

Authors:  M Satoh; M Vazquez-Del Mercado; M E Krzyszczak; Y Li; A Ceribelli; R W Burlingame; T T Webb; E S Sobel; W H Reeves; E K L Chan
Journal:  Lupus       Date:  2011-10-24       Impact factor: 2.911

3.  Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.

Authors:  Angela Ceribelli; Malgorzata E Krzyszczak; Yi Li; Steven J Ross; Jason Y F Chan; Edward K L Chan; Rufus W Burlingame; Tyler T Webb; Michael R Bubb; Eric S Sobel; Westley H Reeves; Minoru Satoh
Journal:  Arthritis Res Ther       Date:  2011-07-22       Impact factor: 5.156

Review 4.  The Role of Autoantibody Testing in Modern Personalized Medicine.

Authors:  Cristiane Kayser; Lívia Almeida Dutra; Edgard Torres Dos Reis-Neto; Charlles Heldan de Moura Castro; Marvin J Fritzler; Luis Eduardo C Andrade
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-04       Impact factor: 10.817

Review 5.  The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications.

Authors:  Sophie P Toya; George E Tzelepis
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

Review 6.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

7.  Autoantibodies are present before the clinical diagnosis of systemic sclerosis.

Authors:  Peter D Burbelo; Sarah M Gordon; Meryl Waldman; Jess D Edison; Dustin J Little; Rodger S Stitt; Wayne T Bailey; James B Hughes; Stephen W Olson
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

8.  Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA.

Authors:  J C Parker; R W Burlingame; T T Webb; C C Bunn
Journal:  Rheumatology (Oxford)       Date:  2008-05-22       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.